Question

A 65-year-old ex-smoker with COPD presents with increasing shortness of breath and sputum production. He is known to have an FEV1 of 45% predicted. Which inhaled therapy is recommended first-line for persistent breathlessness according to NICE guidance?

Accepted Answer

Long-acting beta-2 agonist (LABA) inhaler

Answer

Short-acting anticholinergic inhaler (ipratropium)

Answer

Long-acting muscarinic antagonist (LAMA) inhaler

Answer

Combination LABA + ICS inhaler

Answer

Nebulised salbutamol

Practice question

A 65-year-old ex-smoker with COPD presents with increasing shortness of breath and sputum production. He is known to have an FEV1 of 45% predicted. Which inhaled therapy is recommended first-line for persistent breathlessness according to NICE guidance?